CRISPR Therapeutics (CRSP) Earnings Date, Estimates & Call Transcripts → BlackRock Bets Big on Tiny Biotech (From Behind the Markets) (Ad) Free CRSP Stock Alerts $71.47 -1.48 (-2.03%) (As of 03/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Feb. 21) $1.10 Beat By $0.95 Consensus EPS (Feb. 21) $0.15 Get CRISPR Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CRSP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCRSP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRSP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Bull ReportThe AI Bottleneck No One is Talking AboutRenewable energy is growing at an impressive speed - but not fast enough. This could be one of the greatest periods for the nuclear industry ever.Click here to see who's preparing to meet these needs CRISPR Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20244($1.98)($1.19)($1.61)Q2 20244($2.24)($1.13)($1.67)Q3 20244($1.78)($1.12)($1.52)Q4 20244($2.01)($0.80)($1.49)FY 202416($8.01)($4.24)($6.28)Q1 20252($1.73)($1.50)($1.62)Q2 20252($2.26)($1.37)($1.82)Q3 20252($1.36)($1.25)($1.31)Q4 20252($1.66)($1.14)($1.40)FY 20258($7.01)($5.26)($6.14)CRSP Earnings Date and InformationCRISPR Therapeutics last posted its quarterly earnings results on February 21st, 2024. The reported $1.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.95. The firm had revenue of $201.20 million for the quarter, compared to analysts' expectations of $148.72 million. Its revenue was up 3253.3% on a year-over-year basis. CRISPR Therapeutics has generated ($1.96) earnings per share over the last year (($1.96) diluted earnings per share). Earnings for CRISPR Therapeutics are expected to grow in the coming year, from ($6.24) to ($4.22) per share. CRISPR Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More CRISPR Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 2/21/2024Q4 2023$0.15$1.10+$0.95$1.10$148.72 million$201.20 million11/6/2023Q3 2023($2.04)($1.41)+$0.63($1.41)$5.05 million-8/7/2023Q2 2023($2.13)($0.98)+$1.15($0.98)$1.80 million$70.00 million5/8/2023Q1 2023($1.64)($0.67)+$0.97($0.67)$24.33 million$100.00 million 2/21/2023Q4 2022($2.27)($1.41)+$0.86($1.41)$7.37 million$6.00 million 11/1/2022Q3 2022($2.30)($2.24)+$0.06($2.24)$3.53 million$0.09 million Get the Latest News and Ratings for CRSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISPR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($2.23)($2.40)($0.17)($2.40)$2.20 million$0.20 million5/9/2022Q1 2022($1.91)($2.32)($0.41)($2.32)$2.45 million$0.94 million2/14/2022Q4 2021($1.74)($1.84)($0.10)($1.84)$5.39 million$12.90 million 11/3/2021Q3 2021($1.75)($1.67)+$0.08($1.67)$3.85 million$0.82 million7/29/2021Q2 2021$3.52$9.44+$5.92$9.44$678.05 million$900.70 million4/26/2021Q1 2021($1.47)($1.51)($0.04)($1.51)$4.99 million$0.54 million CRISPR Therapeutics Earnings - Frequently Asked Questions When is CRISPR Therapeutics's earnings date? CRISPR Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on CRSP's earnings history. Did CRISPR Therapeutics beat their earnings estimates last quarter? In the previous quarter, CRISPR Therapeutics (NASDAQ:CRSP) reported $1.10 earnings per share (EPS) to beat the analysts' consensus estimate of $0.15 by $0.95. Learn more on analysts' earnings estimate vs. CRSP's actual earnings. How much revenue does CRISPR Therapeutics generate each year? CRISPR Therapeutics (NASDAQ:CRSP) has a recorded annual revenue of $371.21 million. How much profit does CRISPR Therapeutics generate each year? CRISPR Therapeutics (NASDAQ:CRSP) has a recorded net income of -$153.61 million. CRSP has generated -$1.96 earnings per share over the last four quarters. What is CRISPR Therapeutics's EPS forecast for next year? CRISPR Therapeutics's earnings are expected to grow from ($6.24) per share to ($4.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Revolution Medicines Earnings Date Halozyme Therapeutics Earnings Date Exelixis Earnings Date Krystal Biotech Earnings Date Immunovant Earnings Date Vaxcyte Earnings Date Iovance Biotherapeutics Earnings Date SpringWorks Therapeutics Earnings Date Arcellx Earnings Date Apogee Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earningsBeyond Nvidia: The hidden stars with 200% earnings growth This page (NASDAQ:CRSP) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.